A combination of existing prostate cancer drugs with new drugs at lower doses can be an effective treatment for patients with advanced prostate cancer. During the study, researchers Professor Wayne Tilley and Dr Lisa Butler of the University's Dame Roma Mitchell Cancer Research Laboratories treated the prostate cancer cells with a combination of drugs including bicalutamide (an anti-androgen that opposes the action of androgen on the tumour), and the inhibitors 17AAG and vorinostat.

Full story: newkerala.com